COVID-19 and harm reduction programme implementation: sharing experiences in practice - webinar #2
COVID-19 and harm reduction programme implementation: sharing experiences in practice - webinar #2
, France
- Webinar 1.52.02
Following the first in the series, the aim of this second webinar was to facilitate an interactive and more in-depth discussions issues related to OST and overdose, sharing of practical field experiences, and to build upon previous discussions around generally adapting and maintaining harm reduction services during COVID-19.
Related terms: coronavirus, Opioid agonist therapy, OAT, opioid replacement therapy, Methodone, Suboxone, Buprenorphene, NSP.
English
Transmission: Prevention/infection control Transmission: Injecting drug use Education & training: Peer/volunteer education
Following the first in the series, the aim of this second webinar was to facilitate an interactive and more in-depth discussions issues related to OST and overdose, sharing of practical field experiences, and to build upon previous discussions around generally adapting and maintaining harm reduction services during COVID-19.
Related terms: coronavirus, Opioid agonist therapy, OAT, opioid replacement therapy, Methodone, Suboxone, Buprenorphene, NSP.
English
Transmission: Prevention/infection control Transmission: Injecting drug use Education & training: Peer/volunteer education
